Cargando…

Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosis

BACKGROUND: Paramagnetic rim lesions (PRLs) are an imaging biomarker in multiple sclerosis (MS), associated with a more severe disease. OBJECTIVES: To determine quantitative magnetic resonance imaging (MRI) metrics of PRLs, lesions with diffuse susceptibility-weighted imaging (SWI)-hypointense signa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krajnc, Nik, Schmidbauer, Victor, Leinkauf, Joel, Haider, Lukas, Bsteh, Gabriel, Kasprian, Gregor, Leutmezer, Fritz, Kornek, Barbara, Rommer, Paulus Stefan, Berger, Thomas, Lassmann, Hans, Dal-Bianco, Assunta, Hametner, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580674/ https://www.ncbi.nlm.nih.gov/pubmed/37712486 http://dx.doi.org/10.1177/13524585231197954

Ejemplares similares

Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis
por: Krajnc, Nik, et al.
Publicado: (2022)

Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis
por: Hofmann, Annika, et al.
Publicado: (2023)

Has the pandemic changed treatment strategy in multiple sclerosis?
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial
por: Altmann, Patrick, et al.
Publicado: (2022)

Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study
por: Dal-Bianco, A., et al.
Publicado: (2021)

Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
por: Dal-Bianco, Assunta, et al.
Publicado: (2016)

Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial
por: Altmann, Patrick, et al.
Publicado: (2022)

Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
por: Krajnc, Nik, et al.
Publicado: (2022)

Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
por: Monschein, Tobias, et al.
Publicado: (2020)

Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2023)

Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study
por: Krajnc, Nik, et al.
Publicado: (2022)

Correction to: FLAIR(2) post-processing: improving MS lesion detection in standard MS imaging protocols
por: Zrzavy, Tobias, et al.
Publicado: (2021)

FLAIR(2) post-processing: improving MS lesion detection in standard MS imaging protocols
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis Families
por: Zrzavy, Tobias, et al.
Publicado: (2020)

Iron related changes in MS lesions and their validity to characterize MS lesion types and dynamics with Ultra‐high field magnetic resonance imaging
por: Hametner, Simon, et al.
Publicado: (2018)

The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study
por: Altmann, Patrick, et al.
Publicado: (2021)

B Cell Depletion and SARS‐CoV‐2 Vaccine Responses in Neuroimmunologic Patients
por: Kornek, Barbara, et al.
Publicado: (2022)

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)

Impact of vaccination on COVID‐19 outcome in multiple sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
por: Schurz, Natascha, et al.
Publicado: (2021)

Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease
por: Rath, Jakob, et al.
Publicado: (2022)

Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS
por: Oh, Jiwon, et al.
Publicado: (2021)

Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis
por: Meaton, Isobel, et al.
Publicado: (2022)

RimNet: A deep 3D multimodal MRI architecture for paramagnetic rim lesion assessment in multiple sclerosis
por: Barquero, Germán, et al.
Publicado: (2020)

Metabolic Insights into Iron Deposition in Relapsing-Remitting Multiple Sclerosis via 7 T Magnetic Resonance Spectroscopic Imaging
por: Lipka, Alexandra, et al.
Publicado: (2023)

Serum neurofilament light chain withstands delayed freezing and repeated thawing
por: Altmann, Patrick, et al.
Publicado: (2020)

Structural disconnectivity from paramagnetic rim lesions is related to disability in multiple sclerosis
por: Tozlu, Ceren, et al.
Publicado: (2021)

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis
por: Calvi, Alberto, et al.
Publicado: (2022)

Inner nuclear layer and olfactory threshold are interlinked and reflect inflammatory activity in multiple sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2020)

Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study
por: Blechinger, Stephan, et al.
Publicado: (2021)

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review
por: Krajnc, Nik, et al.
Publicado: (2021)

Measuring Treatment Response in Progressive Multiple Sclerosis—Considerations for Adapting to an Era of Multiple Treatment Options
por: Krajnc, Nik, et al.
Publicado: (2021)

The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2021)

Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2020)

Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis
por: Altmann, Patrick, et al.
Publicado: (2021)

Author Correction: Seven day pre-analytical stability of serum and plasma neurofilament light chain
por: Altmann, Patrick, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uji9j3e9fdehbsbaqbk0pbg5ld